Quintet Private Bank (Europe) S.A. Biogen Inc. Transaction History
Quintet Private Bank (Europe) S.A.
- $1.7 Trillion
- Q1 2025
A detailed history of Quintet Private Bank (Europe) S.A. transactions in Biogen Inc. stock. As of the latest transaction made, Quintet Private Bank (Europe) S.A. holds 927 shares of BIIB stock, worth $112,241. This represents 0.01% of its overall portfolio holdings.
Number of Shares
927
Previous 1,415
34.49%
Holding current value
$112,241
Previous $216 Million
41.38%
% of portfolio
0.01%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding BIIB
# of Institutions
1,011Shares Held
127MCall Options Held
1.77MPut Options Held
2.34M-
Vanguard Group Inc Valley Forge, PA16.7MShares$2.03 Billion0.05% of portfolio
-
Primecap Management CO Pasadena, CA16MShares$1.94 Billion1.94% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$1.76 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.4MShares$896 Million0.05% of portfolio
-
Geode Capital Management, LLC Boston, MA3.7MShares$447 Million0.04% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $17.4B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...